Table 3. Patient data, status and treatment results from MRI scans and from histopathology.

				MRI				Histopathology
Pat.-No.	Age	Clinical status	Resection	Pre- to post-ILP contrast medium enhancement (%)	Max. tumour diameter (mm) before TM-ILP	Tumour depth (mm)	Pre- to post-ILP MRI tumour-volume (%)	Grade of regression (Salzer–Kuntschik)	Histopathologic regression (%)	Entity
1	46	No local recurrence	Resection	25	115	9	55	1	100	Undifferentiated pleomorphic sarcoma
2	61	Late progressive disease	No resection	50	53	17	61			Fibrosarcoma
3	75	No local recurrence	Resection	100	119	8	60	5	5	Dedifferentiated liposarcoma
4	76	Systemic progression of disease	No resection	25	66	2	63			Synovial sarcoma
5	44	No local recurrence	Resection	90	111	10	93	4	80	Myxoid round cell liposarcoma
6	59	No local recurrence	Resection	100	42	2	102	3	93	Undifferentiated pleomorphic sarcoma of the inflammatory type
7	68	Late local recurrence	No resection	50	19	6	22			Fibroblastic sarcoma
8	82	Tumour-related death	No resection	25	37	1	43			Undifferentiated pleomorphic sarcoma (spindle cell)
9	44	Lost to follow-up	—	Lost to follow-up	—	7				Undifferentiated pleomorphic sarcoma
10	52	Local recurrence	Resection	50	68	3	103	3	93	Squamous cell carcinoma
11	80	Ongoing complete remission	No resection	90	25	3	36			Malignant melanoma
Mean				61	66	6	64		74
Median				50	60	6	61		93
Minimum				25	19	1	22		5
Maximum				100	119	17	103		100
SD				31.6	37.6	4.8	27.7		39.4

Abbreviations: SD= standard deviation; TM-ILP=Isolated limb perfusion with TNF-alpha and melphalan; TNF=tumour necrosis factor.